Results 121 to 130 of about 19,741 (164)
Some of the next articles are maybe not open access.
Biotherapeutics and biotherapy of surgical enteropathies
Digestive and Liver Disease, 2002Probiotic agents are living micro-organisms that, upon ingestion, exert health benefits beyond inherent general nutrition. In this context, we must differentiate between biotherapeutics as approved drugs and dietary supplements and food products containing prebiotic bacteria that are not considered drugs. At present, the only biotherapeutic agent which
PERITI P, TONELLI, FRANCESCO
openaire +3 more sources
2013
Nowadays, the designation “peptide epitope” relates to peptide segments, which are essential in protein–protein interactions. The ability to adequately mimic these epitopes will open up an abundance of important applications, varying from interference with undesired protein–protein interactions to the development of protein mimics as synthetic vaccines
openaire +1 more source
Nowadays, the designation “peptide epitope” relates to peptide segments, which are essential in protein–protein interactions. The ability to adequately mimic these epitopes will open up an abundance of important applications, varying from interference with undesired protein–protein interactions to the development of protein mimics as synthetic vaccines
openaire +1 more source
Biotherapeutic approaches to pancreatic cancer
Expert Opinion on Biological Therapy, 2003The incidence of adenocarcinoma of the pancreas has risen steadily over the past four decades. Since pancreatic cancer is usually diagnosed at an advanced stage and because of the lack of effective therapies, the prognosis of such patients is extremely poor.
Lawrence, Rosenberg, Mark, Lipsett
openaire +2 more sources
Biotherapeutic agents and vaginal health
Journal of Applied Microbiology, 2016Treatment of vaginal infection requires different drugs although the recurrence rate post treatment remains high due to adverse effects on the beneficial microbiota. Thus, there are clear clinical advantages for the use of biotherapeutic agents (prebiotics and/or probiotics) for treating these infections.
F H, Al-Ghazzewi, R F, Tester
openaire +2 more sources
Biotherapeutic role of fermented milk
Biotherapy, 1994Fermented milk was used as therapy in infantile diarrhoea due to post-gastroenteritis syndrome. This treatment eliminated the disease in 4.0 days (mean value, SD = 2.8; n = 13) and allowed patients to return to free feeding according to their age. The weight percentile variation during treatment with fermented milk (15 days) was higher in the patients ...
S N, Gonzalez +3 more
openaire +2 more sources
Latest Advancements in Biotherapeutics
Current Pharmaceutical Biotechnologyopenaire +2 more sources
Developability of Biotherapeutics
2015Biopharmaceuticals are emerging as frontline medicines to combat several life-threatening and chronic diseases. However, such medicines are expensive to develop and produce on a commercial scale, contributing to rising healthcare costs. Developability of Biotherapeutics: Computational Approaches describes applications of computational and ...
openaire +1 more source
Biotherapeutic Agents and Disease in Infants
2001Human milk contains many factors that act synergistically or with redundancy in protecting suckling infants from infectious diseases. The rigorous application of the scientific method has shown significant beneficial effects of these specific factors.
openaire +2 more sources
Delivery of Biotherapeutics by Inhalation Aerosol
Critical Reviews in Therapeutic Drug Carrier Systems, 1995The role of inhalation therapy is adapting to changes brought on by advances in several related disciplines. These range from device technology to the molecular and cell biology of the lungs. Acceptable bioavailability and efficacy have been achieved via the oral route for most traditional pharmaceuticals. Unfortunately, injection is the normal mode of
openaire +2 more sources
Half-life extended biotherapeutics
Expert Opinion on Biological Therapy, 2016Many of the biotherapeutics approved or under development suffer from a short half-life necessitating frequent applications in order to maintain a therapeutic concentration over an extended period of time. The implementation of half-life extension strategies allows the generation of long-lasting therapeutics with improved pharmacokinetic and ...
openaire +2 more sources